BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21352280)

  • 1. Papulopustular eruption following diphtheria-tetanus-pertussis vaccine.
    Sasmaz S; Sener S; Garipardic M; Dogan DG
    J Dermatol; 2011 Jun; 38(6):606-7. PubMed ID: 21352280
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythema multiforme due to diphtheria-pertussis-tetanus vaccine.
    Karincaoğlu Y; Aki T; Erguvan-Onal R; Seyhan M
    Pediatr Dermatol; 2007; 24(3):334-5. PubMed ID: 17542900
    [No Abstract]   [Full Text] [Related]  

  • 3. Pityriasis rubra pilaris occurring after vaccination with diphtheria-pertussis-tetanus and oral poliovirus vaccines.
    Mohamed M; Belhadjali H; Hammedi F; Ben Meriem C; Zili J
    Indian J Dermatol Venereol Leprol; 2015; 81(6):618-20. PubMed ID: 26515846
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extremely marked local reaction (erythema, swelling, pain) after the 1st and 2nd DPT vaccination?].
    Wiersbitzky S; Bruns R; Schmidt U
    Kinderarztl Prax; 1993 Aug; 61(6):235-6. PubMed ID: 8411852
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults.
    Hoel T; Wolter JM; Schuerman LM
    Eur J Emerg Med; 2006 Apr; 13(2):67-71. PubMed ID: 16525231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotonic hyporesponsive episodes in eight pertussis vaccine studies.
    Heijbel H; Ciofi degli Atti M; Harzer E; Liese J; Preziosi MP; Rasmussen F; Schmitt HJ; Storsaeter J; Taranger J; Uberall M; Tozzi AE
    Dev Biol Stand; 1997; 89():101-3. PubMed ID: 9272338
    [No Abstract]   [Full Text] [Related]  

  • 11. Nicolau's syndrome in a newborn caused by triple DTP (diphtheria-tetanus-pertussis) vaccination.
    Erkek E; Tuncez F; Sanli C; Duman D; Kurtipek GS; Bagci Y; Ayaslioglu E
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S241-2. PubMed ID: 16631955
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
    CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
    Sato H; Sato Y
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunization against diphtheria and tetanus in children with severe neurological disorders].
    Stehlíková J; Bergmannová V; Domorázková E
    Cesk Pediatr; 1992 Jul; 47(7):417-20. PubMed ID: 1394542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
    Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunizations. Can fever-reducers prevent redness from DTP shots?
    Child Health Alert; 2006 Apr; 24():3. PubMed ID: 16673502
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
    Chan SH; Tan PT; Han HH; Bock HL
    Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA; King J; Law B; Mills E; Willems P
    Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.